Literature DB >> 22936879

AED Trials in Newly Diagnosed Patients: Out With the Old Versus New, in With the New Versus New.

Jaqueline A French.   

Abstract

Entities:  

Year:  2012        PMID： 22936879      PMCID： PMC3423208          DOI： 10.5698/1535-7511-12.4.126

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  5 in total

1.  Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial.

Authors:  Patrick Kwan; Martin J Brodie; Reetta Kälviäinen; Lorraine Yurkewicz; Jerry Weaver; Lloyd E Knapp
Journal:  Lancet Neurol       Date:  2011-08-31       Impact factor: 44.182

Review 2.  Factors determining response to antiepileptic drugs in randomized controlled trials. A systematic review and meta-analysis.

Authors:  Sylvain Rheims; Emilio Perucca; Michel Cucherat; Philippe Ryvlin
Journal:  Epilepsia       Date:  2011-01-26       Impact factor: 5.864

Review 3.  ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.

Authors:  Tracy Glauser; Elinor Ben-Menachem; Blaise Bourgeois; Avital Cnaan; David Chadwick; Carlos Guerreiro; Reetta Kalviainen; Richard Mattson; Emilio Perucca; Torbjorn Tomson
Journal:  Epilepsia       Date:  2006-07       Impact factor: 5.864

Review 4.  Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Authors:  J A French; A M Kanner; J Bautista; B Abou-Khalil; T Browne; C L Harden; W H Theodore; C Bazil; J Stern; S C Schachter; D Bergen; D Hirtz; G D Montouris; M Nespeca; B Gidal; W J Marks; W R Turk; J H Fischer; B Bourgeois; A Wilner; R E Faught; R C Sachdeo; A Beydoun; T A Glauser
Journal:  Neurology       Date:  2004-04-27       Impact factor: 9.910

5.  The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial.

Authors:  Anthony G Marson; Asya M Al-Kharusi; Muna Alwaidh; Richard Appleton; Gus A Baker; David W Chadwick; Celia Cramp; Oliver C Cockerell; Paul N Cooper; Julie Doughty; Barbara Eaton; Carrol Gamble; Peter J Goulding; Stephen J L Howell; Adrian Hughes; Margaret Jackson; Ann Jacoby; Mark Kellett; Geoffrey R Lawson; John Paul Leach; Paola Nicolaides; Richard Roberts; Phil Shackley; Jing Shen; David F Smith; Philip E M Smith; Catrin Tudur Smith; Alessandra Vanoli; Paula R Williamson
Journal:  Lancet       Date:  2007-03-24       Impact factor: 79.321
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.